Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Institut de Cancérologie de Lorraine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
The Clatterbridge Cancer Centre NHS Foundation Trust
St. Jude Children's Research Hospital
University Health Network, Toronto
University of Wisconsin, Madison
Institut Claudius Regaud
Institut Claudius Regaud
Massachusetts General Hospital
Institut Claudius Regaud
Institut Curie
National Cancer Institute, Naples
Nantes University Hospital
Centro di Riferimento Oncologico - Aviano
Virginia Commonwealth University
Providence Health & Services
Centre hospitalier de l'Université de Montréal (CHUM)
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Section for Affective Disorders; Northern Stockholm Psychiatry
Dana-Farber Cancer Institute
Rutgers, The State University of New Jersey
Wake Forest University Health Sciences
The Lymphoma Academic Research Organisation
Centre Leon Berard
Technical University of Munich
Icahn School of Medicine at Mount Sinai
Case Comprehensive Cancer Center
University of California, San Diego
Rabin Medical Center
Ohio State University Comprehensive Cancer Center
Ruijin Hospital
Institut Mutualiste Montsouris
NRG Oncology
Nuclear Imaging Institute
University of California, San Diego
National Minority Quality Forum
Abramson Cancer Center at Penn Medicine
Alliance for Clinical Trials in Oncology